How big is the antiviral therapy market?

It entails several strategies used to develop antiviral therapy including directacting antivirals that target viral proteins enzymes or nucleic acids passive antibodies that neutralize viruses circulating in drug and drugs that target cellular proteins or processes essential for viral replication.Market Analysis and Insights Global Antiviral Therapy MarketThe global Antiviral Therapy market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Generic Drugs accounting for of the Antiviral Therapy global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

Global Antiviral Therapy Market Insights, Forecast to 2028

Code: QYRE-Auto-2G10409

Report

March 2022

Pages:110

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

AbbVie

Abbott

F Hoffmann La Roche Ltd

Bristol Myers Squibb Company

Johnson & Johnson Services Inc.

Antiviral Therapy Market

Antiviral therapy is one of the most exciting branches of virology. It entails several strategies used to develop antiviral therapy, including direct-acting antivirals that target viral proteins, enzymes, or nucleic acids; passive antibodies that neutralize viruses circulating in drug; and drugs that target cellular proteins or processes essential for viral replication.

The global Antiviral Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Generic Drugs accounting for % of the Antiviral Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While HIV segment is altered to an % CAGR throughout this forecast period.

China Antiviral Therapy market size is valued at US$ million in 2021, while the North America and Europe Antiviral Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Antiviral Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antiviral Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antiviral Therapy market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antiviral Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antiviral Therapy market.

Antiviral Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Antiviral Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type

Generic Drugs
Branded Drugs

By Application

HIV
Hepatitis
Herpes
Virus Influenza
Others

By Company

AbbVie Inc.
Abbott
Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Aurobindo Pharma
AstraZeneca

By Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

FEATURED COMPANIES

AbbVie

Abbott

F Hoffmann La Roche Ltd

Bristol Myers Squibb Company

Johnson & Johnson Services Inc.

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antiviral Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Generic Drugs

1.2.3 Branded Drugs

1.3 Market by Application

1.3.1 Global Antiviral Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 HIV

1.3.3 Hepatitis

1.3.4 Herpes

1.3.5 Virus Influenza

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Antiviral Therapy Market Perspective (2017-2028)

2.2 Antiviral Therapy Growth Trends by Region

2.2.1 Antiviral Therapy Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Antiviral Therapy Historic Market Size by Region (2017-2022)

2.2.3 Antiviral Therapy Forecasted Market Size by Region (2023-2028)

2.3 Antiviral Therapy Market Dynamics

2.3.1 Antiviral Therapy Industry Trends

2.3.2 Antiviral Therapy Market Drivers

2.3.3 Antiviral Therapy Market Challenges

2.3.4 Antiviral Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antiviral Therapy Players by Revenue

3.1.1 Global Top Antiviral Therapy Players by Revenue (2017-2022)

3.1.2 Global Antiviral Therapy Revenue Market Share by Players (2017-2022)

3.2 Global Antiviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Antiviral Therapy Revenue

3.4 Global Antiviral Therapy Market Concentration Ratio

3.4.1 Global Antiviral Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antiviral Therapy Revenue in 2021

3.5 Antiviral Therapy Key Players Head office and Area Served

3.6 Key Players Antiviral Therapy Product Solution and Service

3.7 Date of Enter into Antiviral Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Antiviral Therapy Breakdown Data by Type

4.1 Global Antiviral Therapy Historic Market Size by Type (2017-2022)

4.2 Global Antiviral Therapy Forecasted Market Size by Type (2023-2028)

5 Antiviral Therapy Breakdown Data by Application

5.1 Global Antiviral Therapy Historic Market Size by Application (2017-2022)

5.2 Global Antiviral Therapy Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Antiviral Therapy Market Size (2017-2028)

6.2 North America Antiviral Therapy Market Size by Type

6.2.1 North America Antiviral Therapy Market Size by Type (2017-2022)

6.2.2 North America Antiviral Therapy Market Size by Type (2023-2028)

6.2.3 North America Antiviral Therapy Market Share by Type (2017-2028)

6.3 North America Antiviral Therapy Market Size by Application

6.3.1 North America Antiviral Therapy Market Size by Application (2017-2022)

6.3.2 North America Antiviral Therapy Market Size by Application (2023-2028)

6.3.3 North America Antiviral Therapy Market Share by Application (2017-2028)

6.4 North America Antiviral Therapy Market Size by Country

6.4.1 North America Antiviral Therapy Market Size by Country (2017-2022)

6.4.2 North America Antiviral Therapy Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Antiviral Therapy Market Size (2017-2028)

7.2 Europe Antiviral Therapy Market Size by Type

7.2.1 Europe Antiviral Therapy Market Size by Type (2017-2022)

7.2.2 Europe Antiviral Therapy Market Size by Type (2023-2028)

7.2.3 Europe Antiviral Therapy Market Share by Type (2017-2028)

7.3 Europe Antiviral Therapy Market Size by Application

7.3.1 Europe Antiviral Therapy Market Size by Application (2017-2022)

7.3.2 Europe Antiviral Therapy Market Size by Application (2023-2028)

7.3.3 Europe Antiviral Therapy Market Share by Application (2017-2028)

7.4 Europe Antiviral Therapy Market Size by Country

7.4.1 Europe Antiviral Therapy Market Size by Country (2017-2022)

7.4.2 Europe Antiviral Therapy Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antiviral Therapy Market Size (2017-2028)

8.2 Asia-Pacific Antiviral Therapy Market Size by Type

8.2.1 Asia-Pacific Antiviral Therapy Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Antiviral Therapy Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Antiviral Therapy Market Share by Type (2017-2028)

8.3 Asia-Pacific Antiviral Therapy Market Size by Application

8.3.1 Asia-Pacific Antiviral Therapy Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Antiviral Therapy Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Antiviral Therapy Market Share by Application (2017-2028)

8.4 Asia-Pacific Antiviral Therapy Market Size by Region

8.4.1 Asia-Pacific Antiviral Therapy Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Antiviral Therapy Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Antiviral Therapy Market Size (2017-2028)

9.2 Latin America Antiviral Therapy Market Size by Type

9.2.1 Latin America Antiviral Therapy Market Size by Type (2017-2022)

9.2.2 Latin America Antiviral Therapy Market Size by Type (2023-2028)

9.2.3 Latin America Antiviral Therapy Market Share by Type (2017-2028)

9.3 Latin America Antiviral Therapy Market Size by Application

9.3.1 Latin America Antiviral Therapy Market Size by Application (2017-2022)

9.3.2 Latin America Antiviral Therapy Market Size by Application (2023-2028)

9.3.3 Latin America Antiviral Therapy Market Share by Application (2017-2028)

9.4 Latin America Antiviral Therapy Market Size by Country

9.4.1 Latin America Antiviral Therapy Market Size by Country (2017-2022)

9.4.2 Latin America Antiviral Therapy Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antiviral Therapy Market Size (2017-2028)

10.2 Middle East & Africa Antiviral Therapy Market Size by Type

10.2.1 Middle East & Africa Antiviral Therapy Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Antiviral Therapy Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Antiviral Therapy Market Share by Type (2017-2028)

10.3 Middle East & Africa Antiviral Therapy Market Size by Application

10.3.1 Middle East & Africa Antiviral Therapy Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Antiviral Therapy Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Antiviral Therapy Market Share by Application (2017-2028)

10.4 Middle East & Africa Antiviral Therapy Market Size by Country

10.4.1 Middle East & Africa Antiviral Therapy Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Antiviral Therapy Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 AbbVie Inc.

11.1.1 AbbVie Inc. Company Details

11.1.2 AbbVie Inc. Business Overview

11.1.3 AbbVie Inc. Antiviral Therapy Introduction

11.1.4 AbbVie Inc. Revenue in Antiviral Therapy Business (2017-2022)

11.1.5 AbbVie Inc. Recent Developments

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Antiviral Therapy Introduction

11.2.4 Abbott Revenue in Antiviral Therapy Business (2017-2022)

11.2.5 Abbott Recent Developments

11.3 F. Hoffmann-La Roche Ltd

11.3.1 F. Hoffmann-La Roche Ltd Company Details

11.3.2 F. Hoffmann-La Roche Ltd Business Overview

11.3.3 F. Hoffmann-La Roche Ltd Antiviral Therapy Introduction

11.3.4 F. Hoffmann-La Roche Ltd Revenue in Antiviral Therapy Business (2017-2022)

11.3.5 F. Hoffmann-La Roche Ltd Recent Developments

11.4 Bristol-Myers Squibb Company

11.4.1 Bristol-Myers Squibb Company Company Details

11.4.2 Bristol-Myers Squibb Company Business Overview

11.4.3 Bristol-Myers Squibb Company Antiviral Therapy Introduction

11.4.4 Bristol-Myers Squibb Company Revenue in Antiviral Therapy Business (2017-2022)

11.4.5 Bristol-Myers Squibb Company Recent Developments

11.5 Johnson & Johnson Services, Inc.

11.5.1 Johnson & Johnson Services, Inc. Company Details

11.5.2 Johnson & Johnson Services, Inc. Business Overview

11.5.3 Johnson & Johnson Services, Inc. Antiviral Therapy Introduction

11.5.4 Johnson & Johnson Services, Inc. Revenue in Antiviral Therapy Business (2017-2022)

11.5.5 Johnson & Johnson Services, Inc. Recent Developments

11.6 Merck & Co., Inc.

11.6.1 Merck & Co., Inc. Company Details

11.6.2 Merck & Co., Inc. Business Overview

11.6.3 Merck & Co., Inc. Antiviral Therapy Introduction

11.6.4 Merck & Co., Inc. Revenue in Antiviral Therapy Business (2017-2022)

11.6.5 Merck & Co., Inc. Recent Developments

11.7 Gilead Sciences, Inc.

11.7.1 Gilead Sciences, Inc. Company Details

11.7.2 Gilead Sciences, Inc. Business Overview

11.7.3 Gilead Sciences, Inc. Antiviral Therapy Introduction

11.7.4 Gilead Sciences, Inc. Revenue in Antiviral Therapy Business (2017-2022)

11.7.5 Gilead Sciences, Inc. Recent Developments

11.8 GlaxoSmithKline plc

11.8.1 GlaxoSmithKline plc Company Details

11.8.2 GlaxoSmithKline plc Business Overview

11.8.3 GlaxoSmithKline plc Antiviral Therapy Introduction

11.8.4 GlaxoSmithKline plc Revenue in Antiviral Therapy Business (2017-2022)

11.8.5 GlaxoSmithKline plc Recent Developments

11.9 Aurobindo Pharma

11.9.1 Aurobindo Pharma Company Details

11.9.2 Aurobindo Pharma Business Overview

11.9.3 Aurobindo Pharma Antiviral Therapy Introduction

11.9.4 Aurobindo Pharma Revenue in Antiviral Therapy Business (2017-2022)

11.9.5 Aurobindo Pharma Recent Developments

11.10 AstraZeneca

11.10.1 AstraZeneca Company Details

11.10.2 AstraZeneca Business Overview

11.10.3 AstraZeneca Antiviral Therapy Introduction

11.10.4 AstraZeneca Revenue in Antiviral Therapy Business (2017-2022)

11.10.5 AstraZeneca Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Abbott

F Hoffmann La Roche Ltd

Bristol Myers Squibb Company

Johnson & Johnson Services Inc.

List of Tables

Table 1. Global Antiviral Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Generic Drugs

Table 3. Key Players of Branded Drugs

Table 4. Global Antiviral Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 5. Global Antiviral Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Antiviral Therapy Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global Antiviral Therapy Market Share by Region (2017-2022)

Table 8. Global Antiviral Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global Antiviral Therapy Market Share by Region (2023-2028)

Table 10. Antiviral Therapy Market Trends

Table 11. Antiviral Therapy Market Drivers

Table 12. Antiviral Therapy Market Challenges

Table 13. Antiviral Therapy Market Restraints

Table 14. Global Antiviral Therapy Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global Antiviral Therapy Revenue Share by Players (2017-2022)

Table 16. Global Top Antiviral Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapy as of 2021)

Table 17. Ranking of Global Top Antiviral Therapy Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by Antiviral Therapy Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Antiviral Therapy Product Solution and Service

Table 21. Date of Enter into Antiviral Therapy Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Antiviral Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global Antiviral Therapy Revenue Market Share by Type (2017-2022)

Table 25. Global Antiviral Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global Antiviral Therapy Revenue Market Share by Type (2023-2028)

Table 27. Global Antiviral Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global Antiviral Therapy Revenue Share by Application (2017-2022)

Table 29. Global Antiviral Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global Antiviral Therapy Revenue Share by Application (2023-2028)

Table 31. North America Antiviral Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 32. North America Antiviral Therapy Market Size by Type (2023-2028) & (US$ Million)

Table 33. North America Antiviral Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 34. North America Antiviral Therapy Market Size by Application (2023-2028) & (US$ Million)

Table 35. North America Antiviral Therapy Market Size by Country (2017-2022) & (US$ Million)

Table 36. North America Antiviral Therapy Market Size by Country (2023-2028) & (US$ Million)

Table 37. Europe Antiviral Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 38. Europe Antiviral Therapy Market Size by Type (2023-2028) & (US$ Million)

Table 39. Europe Antiviral Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 40. Europe Antiviral Therapy Market Size by Application (2023-2028) & (US$ Million)

Table 41. Europe Antiviral Therapy Market Size by Country (2017-2022) & (US$ Million)

Table 42. Europe Antiviral Therapy Market Size by Country (2023-2028) & (US$ Million)

Table 43. Asia Pacific Antiviral Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 44. Asia Pacific Antiviral Therapy Market Size by Type (2023-2028) & (US$ Million)

Table 45. Asia Pacific Antiviral Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 46. Asia Pacific Antiviral Therapy Market Size by Application (2023-2028) & (US$ Million)

Table 47. Asia Pacific Antiviral Therapy Market Size by Region (2017-2022) & (US$ Million)

Table 48. Asia Pacific Antiviral Therapy Market Size by Region (2023-2028) & (US$ Million)

Table 49. Latin America Antiviral Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 50. Latin America Antiviral Therapy Market Size by Type (2023-2028) & (US$ Million)

Table 51. Latin America Antiviral Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 52. Latin America Antiviral Therapy Market Size by Application (2023-2028) & (US$ Million)

Table 53. Latin America Antiviral Therapy Market Size by Country (2017-2022) & (US$ Million)

Table 54. Latin America Antiviral Therapy Market Size by Country (2023-2028) & (US$ Million)

Table 55. Middle East and Africa Antiviral Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 56. Middle East and Africa Antiviral Therapy Market Size by Type (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Antiviral Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Antiviral Therapy Market Size by Application (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Antiviral Therapy Market Size by Country (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Antiviral Therapy Market Size by Country (2023-2028) & (US$ Million)

Table 61. AbbVie Inc. Company Details

Table 62. AbbVie Inc. Business Overview

Table 63. AbbVie Inc. Antiviral Therapy Product

Table 64. AbbVie Inc. Revenue in Antiviral Therapy Business (2017-2022) & (US$ Million)

Table 65. AbbVie Inc. Recent Developments

Table 66. Abbott Company Details

Table 67. Abbott Business Overview

Table 68. Abbott Antiviral Therapy Product

Table 69. Abbott Revenue in Antiviral Therapy Business (2017-2022) & (US$ Million)

Table 70. Abbott Recent Developments

Table 71. F. Hoffmann-La Roche Ltd Company Details

Table 72. F. Hoffmann-La Roche Ltd Business Overview

Table 73. F. Hoffmann-La Roche Ltd Antiviral Therapy Product

Table 74. F. Hoffmann-La Roche Ltd Revenue in Antiviral Therapy Business (2017-2022) & (US$ Million)

Table 75. F. Hoffmann-La Roche Ltd Recent Developments

Table 76. Bristol-Myers Squibb Company Company Details

Table 77. Bristol-Myers Squibb Company Business Overview

Table 78. Bristol-Myers Squibb Company Antiviral Therapy Product

Table 79. Bristol-Myers Squibb Company Revenue in Antiviral Therapy Business (2017-2022) & (US$ Million)

Table 80. Bristol-Myers Squibb Company Recent Developments

Table 81. Johnson & Johnson Services, Inc. Company Details

Table 82. Johnson & Johnson Services, Inc. Business Overview

Table 83. Johnson & Johnson Services, Inc. Antiviral Therapy Product

Table 84. Johnson & Johnson Services, Inc. Revenue in Antiviral Therapy Business (2017-2022) & (US$ Million)

Table 85. Johnson & Johnson Services, Inc. Recent Developments

Table 86. Merck & Co., Inc. Company Details

Table 87. Merck & Co., Inc. Business Overview

Table 88. Merck & Co., Inc. Antiviral Therapy Product

Table 89. Merck & Co., Inc. Revenue in Antiviral Therapy Business (2017-2022) & (US$ Million)

Table 90. Merck & Co., Inc. Recent Developments

Table 91. Gilead Sciences, Inc. Company Details

Table 92. Gilead Sciences, Inc. Business Overview

Table 93. Gilead Sciences, Inc. Antiviral Therapy Product

Table 94. Gilead Sciences, Inc. Revenue in Antiviral Therapy Business (2017-2022) & (US$ Million)

Table 95. Gilead Sciences, Inc. Recent Developments

Table 96. GlaxoSmithKline plc Company Details

Table 97. GlaxoSmithKline plc Business Overview

Table 98. GlaxoSmithKline plc Antiviral Therapy Product

Table 99. GlaxoSmithKline plc Revenue in Antiviral Therapy Business (2017-2022) & (US$ Million)

Table 100. GlaxoSmithKline plc Recent Developments

Table 101. Aurobindo Pharma Company Details

Table 102. Aurobindo Pharma Business Overview

Table 103. Aurobindo Pharma Antiviral Therapy Product

Table 104. Aurobindo Pharma Revenue in Antiviral Therapy Business (2017-2022) & (US$ Million)

Table 105. Aurobindo Pharma Recent Developments

Table 106. AstraZeneca Company Details

Table 107. AstraZeneca Business Overview

Table 108. AstraZeneca Antiviral Therapy Product

Table 109. AstraZeneca Revenue in Antiviral Therapy Business (2017-2022) & (US$ Million)

Table 110. AstraZeneca Recent Developments

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Antiviral Therapy Market Share by Type: 2021 VS 2028

Figure 2. Generic Drugs Features

Figure 3. Branded Drugs Features

Figure 4. Global Antiviral Therapy Market Share by Application: 2021 VS 2028

Figure 5. HIV Case Studies

Figure 6. Hepatitis Case Studies

Figure 7. Herpes Case Studies

Figure 8. Virus Influenza Case Studies

Figure 9. Others Case Studies

Figure 10. Antiviral Therapy Report Years Considered

Figure 11. Global Antiviral Therapy Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 12. Global Antiviral Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Antiviral Therapy Market Share by Region: 2021 VS 2028

Figure 14. Global Antiviral Therapy Market Share by Players in 2021

Figure 15. Global Top Antiviral Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapy as of 2021)

Figure 16. The Top 10 and 5 Players Market Share by Antiviral Therapy Revenue in 2021

Figure 17. North America Antiviral Therapy Market Size YoY (2017-2028) & (US$ Million)

Figure 18. North America Antiviral Therapy Market Size Market Share by Type (2017-2028)

Figure 19. North America Antiviral Therapy Market Size Market Share by Application (2017-2028)

Figure 20. North America Antiviral Therapy Market Size Share by Country (2017-2028)

Figure 21. United States Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Canada Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Europe Antiviral Therapy Market Size YoY (2017-2028) & (US$ Million)

Figure 24. Europe Antiviral Therapy Market Size Market Share by Type (2017-2028)

Figure 25. Europe Antiviral Therapy Market Size Market Share by Application (2017-2028)

Figure 26. Europe Antiviral Therapy Market Size Share by Country (2017-2028)

Figure 27. Germany Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. France Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. U.K. Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Italy Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Russia Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Nordic Countries Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Asia-Pacific Antiviral Therapy Market Size YoY (2017-2028) & (US$ Million)

Figure 34. Asia Pacific Antiviral Therapy Market Size Market Share by Type (2017-2028)

Figure 35. Asia Pacific Antiviral Therapy Market Size Market Share by Application (2017-2028)

Figure 36. Asia Pacific Antiviral Therapy Market Size Share by Region (2017-2028)

Figure 37. China Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Japan Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. South Korea Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Southeast Asia Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. India Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Australia Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 43. Latin America Antiviral Therapy Market Size YoY (2017-2028) & (US$ Million)

Figure 44. Latin America Antiviral Therapy Market Size Market Share by Type (2017-2028)

Figure 45. Latin America Antiviral Therapy Market Size Market Share by Application (2017-2028)

Figure 46. Latin America Antiviral Therapy Market Size Share by Country (2017-2028)

Figure 47. Mexico Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Brazil Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 49. Middle East & Africa Antiviral Therapy Market Size YoY (2017-2028) & (US$ Million)

Figure 50. Middle East and Africa Antiviral Therapy Market Size Market Share by Type (2017-2028)

Figure 51. Middle East and Africa Antiviral Therapy Market Size Market Share by Application (2017-2028)

Figure 52. Middle East and Africa Antiviral Therapy Market Size Share by Country (2017-2028)

Figure 53. Turkey Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Saudi Arabia Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. UAE Antiviral Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. AbbVie Inc. Revenue Growth Rate in Antiviral Therapy Business (2017-2022)

Figure 57. Abbott Revenue Growth Rate in Antiviral Therapy Business (2017-2022)

Figure 58. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Antiviral Therapy Business (2017-2022)

Figure 59. Bristol-Myers Squibb Company Revenue Growth Rate in Antiviral Therapy Business (2017-2022)

Figure 60. Johnson & Johnson Services, Inc. Revenue Growth Rate in Antiviral Therapy Business (2017-2022)

Figure 61. Merck & Co., Inc. Revenue Growth Rate in Antiviral Therapy Business (2017-2022)

Figure 62. Gilead Sciences, Inc. Revenue Growth Rate in Antiviral Therapy Business (2017-2022)

Figure 63. GlaxoSmithKline plc Revenue Growth Rate in Antiviral Therapy Business (2017-2022)

Figure 64. Aurobindo Pharma Revenue Growth Rate in Antiviral Therapy Business (2017-2022)

Figure 65. AstraZeneca Revenue Growth Rate in Antiviral Therapy Business (2017-2022)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antiviral Therapy Market Insights, Forecast to 2028

Published Date: March 2022

Report Code: QYRE-Auto-2G10409

Global Antiviral Therapy Market Insights, Forecast to 2028

FEATURED COMPANIES

Antiviral Therapy Market

By Type

By Application

By Company

By Region

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26K6048

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-20L6129

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-4F6384

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-16N6009

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions